Paper23201752
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
Costa PM and 6 others. Hum Mol Genet, 2013. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Papers, record 23201752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23201752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Glioblastoma | Major topic |
| Indoles | Major topic |
| MicroRNAs | Major topic |
| Pyrroles | Major topic |
| Angiogenesis Inhibitors | |
| Animals | |
| Apoptosis Regulatory Proteins | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Down-Regulation | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Mice | |
| PTEN Phosphohydrolase | |
| RNA-Binding Proteins | |
| Signal Transduction | |
| Sunitinib | |
| Up-Regulation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 NS066955 | NINDS NIH HHS | United States | R01NS066955 | PubMed and NIH | NIH RePORTER |
| R01 NS073610 | NINDS NIH HHS | United States | R01NS073610 | PubMed and NIH | NIH RePORTER |
| 1R01NS066955-01 | NINDS NIH HHS | United States | R01NS066955 | PubMed and NIH | NIH RePORTER |
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20048743 | Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status. | Lab Invest | 2010 | https://conductscience.org/library/papers/20048743 | PubMed |
| 2 | 20425605 | Advances in the treatment of malignant gliomas. | Curr Oncol Rep | 2010 | https://conductscience.org/library/papers/20425605 | PubMed |
| 3 | 21636706 | Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. | Neuro Oncol | 2011 | https://conductscience.org/library/papers/21636706 | PubMed |
| 4 | 21063898 | PI3Kinase signaling in glioblastoma. | J Neurooncol | 2011 | https://conductscience.org/library/papers/21063898 | PubMed |
| 5 | 21772280 | Inflammation meets cancer, with NF-κB as the matchmaker. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21772280 | PubMed |
| 6 | 22283740 | P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK. | Free Radic Res | 2012 | https://conductscience.org/library/papers/22283740 | PubMed |
| 7 | 18829576 | MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. | Cancer Res | 2008 | https://conductscience.org/library/papers/18829576 | PubMed |
| 8 | 22766795 | Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma. | Mod Pathol | 2012 | https://conductscience.org/library/papers/22766795 | PubMed |
| 9 | 20872043 | Phase II study of sunitinib malate in patients with recurrent high-grade glioma. | J Neurooncol | 2011 | https://conductscience.org/library/papers/20872043 | PubMed |
| 10 | 22043967 | miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. | Immunology | 2012 | https://conductscience.org/library/papers/22043967 | PubMed |
| 11 | 15143321 | Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. | Nat Rev Genet | 2004 | https://conductscience.org/library/papers/15143321 | PubMed |
| 12 | 19935707 | The microRNA network and tumor metastasis. | Oncogene | 2010 | https://conductscience.org/library/papers/19935707 | PubMed |
| 13 | 19010882 | Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. | Cancer Res | 2008 | https://conductscience.org/library/papers/19010882 | PubMed |
| 14 | 15317660 | Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). | Am J Physiol Cell Physiol | 2004 | https://conductscience.org/library/papers/15317660 | PubMed |
| 15 | 20129251 | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20129251 | PubMed |
| 16 | 16039986 | Extensive modulation of a set of microRNAs in primary glioblastoma. | Biochem Biophys Res Commun | 2005 | https://conductscience.org/library/papers/16039986 | PubMed |
| 17 | 20530750 | p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism. | FASEB J | 2010 | https://conductscience.org/library/papers/20530750 | PubMed |
| 18 | 17466617 | p53 and NF-kappaB crosstalk: IKKalpha tips the balance. | Mol Cell | 2007 | https://conductscience.org/library/papers/17466617 | PubMed |
| 19 | 20844972 | Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas. | Target Oncol | 2010 | https://conductscience.org/library/papers/20844972 | PubMed |
| 20 | 20703300 | Mammalian microRNAs predominantly act to decrease target mRNA levels. | Nature | 2010 | https://conductscience.org/library/papers/20703300 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40622635 | MiR-124 and MiR-155 as Therapeutic Targets in Microglia-Mediated Inflammation in Multiple Sclerosis. | Cell Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40622635 | PubMed |
| 38760847 | Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38760847 | PubMed |
| 38059120 | Engineered smart materials for RNA based molecular therapy to treat Glioblastoma. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38059120 | PubMed |
| 37414973 | The Significant Role of microRNAs in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application. | Cell Mol Neurobiol | 2023 | https://conductscience.org/library/papers/37414973 | PubMed |
| 37183560 | Exosome and epithelial-mesenchymal transition: A complex secret of cancer progression. | J Cell Mol Med | 2023 | https://conductscience.org/library/papers/37183560 | PubMed |
| 35787387 | Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35787387 | PubMed |
| 35421166 | MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma. | PLoS One | 2022 | https://conductscience.org/library/papers/35421166 | PubMed |
| 35405312 | Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. | Mol Ther | 2022 | https://conductscience.org/library/papers/35405312 | PubMed |
| 34359852 | Melatonin Treatment Improves Renal Fibrosis via miR-4516/SIAH3/PINK1 Axis. | Cells | 2021 | https://conductscience.org/library/papers/34359852 | PubMed |
| 34337348 | Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. | Cancer Drug Resist | 2021 | https://conductscience.org/library/papers/34337348 | PubMed |
| 34273059 | Exosomal noncoding RNAs: key players in glioblastoma drug resistance. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/34273059 | PubMed |
| 33800703 | Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33800703 | PubMed |
| 33176185 | Targeted delivery of small noncoding RNA for glioblastoma. | Cancer Lett | 2021 | https://conductscience.org/library/papers/33176185 | PubMed |
| 32888084 | Lauroylated Histidine-Enriched S413-PV Peptide as an Efficient Gene Silencing Mediator in Cancer Cells. | Pharm Res | 2020 | https://conductscience.org/library/papers/32888084 | PubMed |
| 32283739 | Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32283739 | PubMed |
| 32252322 | The Emerging Roles of Exosomes as EMT Regulators in Cancer. | Cells | 2020 | https://conductscience.org/library/papers/32252322 | PubMed |
| 32178454 | The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32178454 | PubMed |
| 32098401 | Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32098401 | PubMed |
| 31482067 | Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma. | Front Oncol | 2019 | https://conductscience.org/library/papers/31482067 | PubMed |
| 31186751 | Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31186751 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CASP7 | 840 | PubTator's text mining | https://conductscience.org/library/genes/840 | NCBI Gene |
| MIR21 | 406991 | PubTator's text mining | https://conductscience.org/library/genes/406991 | NCBI Gene |
| PDCD4 | 27250 | PubTator's text mining | https://conductscience.org/library/genes/27250 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23201752
GET https://conductscience.org/api/papers/v1/23201752/references?page=2